DTIL — Precision Biosciences Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousMicro CapValue Trap

Annual balance sheet for Precision Biosciences, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	89.8	144	190	117	86.3
Net Total Accounts Receivable
Net Total Receivables	10	0.488	0.72	12.8	1.7
Prepaid Expenses
Total Other Current Assets
Total Current Assets	106	162	199	136	95
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	41.5	29.3	23.2	14.6	10.2
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	150	211	238	160	136
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	42.8	36	59.7	50	15
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	106	120	178	141	80
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Other Equity
Total Equity	44.4	91.2	60.4	18.9	56.4
Total Liabilities & Shareholders' Equity	150	211	238	160	136
Total Common Shares Outstanding